Analyst Ratings & Targets

Upgrades, downgrades, and price target moves across sectors.

  • 18 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Analyst Ratings & Targets

marketscreener.com
250 words

Symrise AG: Bernstein sticks Neutral

Bernstein analyst Victoria Nice maintains his Neutral opinion on the stock. The target price remains set at EUR 99. Symrise AG: Bernstein sticks Neutral Published on 10/08/2026 at 03:40 am EDT Latest news about Symrise AG Income Statement and Estimates Symrise: Cash conversion…

stocktitan.net
313 words

Quince Therapeutics: Perceptive reports 8.4% stake

Warrants for 456,427 shares are excluded from a reported stake in Quince Therapeutics (QNCX). Stock Titan - [SCHEDULE 13G] Quince Therapeutics, Inc. Passive Investment Disclosure (>5%) Quince Therapeutics: Perceptive reports 8.4% stake Warrant shares are excluded from reported ownership until a specified trial or termination…

marketscreener.com
69 words

Ahold Delhaize N.V.: Bernstein remains Neutral

Bernstein analyst Callum Elliott maintains his Neutral opinion on the stock. The target price is unchanged at EUR 38. Food Retail & Distribution Ahold Delhaize N.V.: Bernstein remains Neutral Published on 10/13/2026 at 05:59 am EDT Latest news about Ahold Delhaize N.V. Chart Ahold Delhaize N.V. Income…